Main Menu

Preclinical Modelling of Paediatric Cancer Evolution Team

Dr Alejandra Bruna's team is studying the phenotypic changes occurring through treatment to explore modulation of transcription dynamics as a therapeutic strategy in aggressive solid paediatric cancers.

Team leader

Dr Alejandra Bruna

Dr Alejandra Bruna

Dr Alejandra Bruna leads the Preclinical Modelling of Paediatric Cancer Evolution team. She has experience leading and contributing to preclinical programmes using improved patient-derived tumour models.

ORCID 0000-0003-1214-9665